| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO
1 company
Luly Jay R. is a President And CEO at ENANTA PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $13.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2015 | ENTA Enanta Pharmaceuticals Inc | President And CEO | Sell | 15,000 | $35.35 | $530,289.00 | -3.0% | |
| Jan 5, 2015 | ENTA Enanta Pharmaceuticals Inc | President And CEO | Sell | 15,000 | $50.43 | $756,462.50 | -1.5% |